New Delhi, Jan. 2 -- The growing popularity of obesity drugs is expected to spur Indian pharma companies to sign licensing partnerships and distribution deals as they eye the lucrative segment. Indian... Read More
New Delhi, Dec. 19 -- Pfizer India and Cipla announced a partnership on Friday in which Cipla will exclusively market and distribute four Pfizer brands in India to increase their reach. These include... Read More
New Delhi, Dec. 16 -- Even as large hospitals in India rapidly consolidate, smaller corporate chains are aggressively expanding with an aim to grow into regional leaders - which, experts say, in turn,... Read More
MUMBAI, Dec. 13 -- Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of Rs.2,200 per week. For a four-week course, the entry 0.25 m... Read More
MUMBAI, Dec. 13 -- Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of Rs.2,200 per week. For a four-week course, the entry 0.25 m... Read More
MUMBAI, Dec. 12 -- Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, pricing the entry 0.25 mg dose at Rs.8,800 for a four-week course. The launch comes ... Read More
MUMBAI, Dec. 12 -- Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, with a headline starting price of Rs.2,200 per week. For a four-week course, the ent... Read More
New Delhi, Dec. 10 -- French pharmaceutical group Servier is sharpening its India strategy with a string of new oncology launches focused on rare cancers, plans for local manufacturing of active ingre... Read More
New Delhi, Dec. 6 -- Biocon Ltd will integrate Biocon Biologics Ltd as a wholly owned subsidiary in a deal valuing the unit at $5.5 billion, the company said on Saturday. Biocon will acquire the rema... Read More
Mumbai, Dec. 6 -- On 2 December, the Delhi high court allowed domestic drugmaker Dr Reddy's Laboratories Ltd to manufacture the blockbuster weight-loss injection semaglutide, for which global pharma g... Read More